ATE348818T1 - Cyclische hydroxylamine als psychoactive verbindugen - Google Patents

Cyclische hydroxylamine als psychoactive verbindugen

Info

Publication number: ATE348818T1
Authority: AT; Austria
Prior art keywords: represent; psychoactive compounds; unsaturated ring; ring selected; represent hydrogen
Prior art date: 2003-06-12

Application number

AT04735609T

Other languages

English (en)

Inventor

Philip Parsons

Silvia Trasciatti

Sergio Rosini

Michael Annis

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-12

Filing date

2004-06-01

Publication date

2007-01-15

2003-06-12 Priority claimed from GB0313628A external-priority patent/GB0313628D0/en

2003-12-08 Priority claimed from GB0328439A external-priority patent/GB0328439D0/en

2004-06-01 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2007-01-15 Application granted granted Critical

2007-01-15 Publication of ATE348818T1 publication Critical patent/ATE348818T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 2
150000002443 hydroxylamines Chemical class 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical group C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 abstract 1
WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

AT04735609T 2003-06-12 2004-06-01 Cyclische hydroxylamine als psychoactive verbindugen ATE348818T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0313628A GB0313628D0 (en)	2003-06-12	2003-06-12	Psychoactive compounds
GB0328439A GB0328439D0 (en)	2003-12-08	2003-12-08	Psychoactive compounds

Publications (1)

Publication Number	Publication Date
ATE348818T1 true ATE348818T1 (de)	2007-01-15

Family

ID=33554147

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04735609T ATE348818T1 (de)	2003-06-12	2004-06-01	Cyclische hydroxylamine als psychoactive verbindugen

Country Status (19)

Country	Link
US (4)	US7842689B2 (de)
EP (1)	EP1631557B1 (de)
JP (1)	JP4648899B2 (de)
KR (1)	KR20060018253A (de)
AT (1)	ATE348818T1 (de)
AU (1)	AU2004247462B2 (de)
BR (1)	BRPI0411124A (de)
CA (1)	CA2526209A1 (de)
DE (1)	DE602004003810T2 (de)
DK (1)	DK1631557T3 (de)
ES (1)	ES2278321T3 (de)
MX (1)	MXPA05013464A (de)
NO (1)	NO20060178L (de)
NZ (1)	NZ544028A (de)
PL (1)	PL1631557T3 (de)
PT (1)	PT1631557E (de)
RU (1)	RU2006101055A (de)
SI (1)	SI1631557T1 (de)
WO (1)	WO2004111021A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20060258A1 (it) *	2006-02-13	2007-08-14	Abiogen Pharma Spa	Procedimento per la preparazione di 2-4 idrossi-3-morfolini-2-cicloesenone
UY32858A (es) *	2009-08-31	2011-03-31	Abbott Healthcare Products Bv	Derivados de (tio)morfolina como moduladores de sip
EP2345639A1 (de) *	2009-12-24	2011-07-20	ABIOGEN PHARMA S.p.A.	Cyclische Hydroxylaminderivate, deren Herstellung und Verwendung als Antioxidantien
TWI522361B (zh)	2010-07-09	2016-02-21	艾伯維公司	作為s1p調節劑的稠合雜環衍生物
TW201206893A (en) *	2010-07-09	2012-02-16	Abbott Healthcare Products Bv	Bisaryl (thio) morpholine derivatives as S1P modulators
TW201643169A (zh)	2010-07-09	2016-12-16	艾伯維股份有限公司	作為s1p調節劑的螺-哌啶衍生物
EP2808023A1 (de) *	2013-05-30	2014-12-03	Université Pierre et Marie Curie (Paris 6)	Neues Arzneimittel zur Behandlung und/oder Vorbeugung von Depressionserkrankungen
US11535632B2 (en)	2019-10-31	2022-12-27	ESCAPE Bio, Inc.	Solid forms of an S1P-receptor modulator

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4241071A (en) *	1977-01-27	1980-12-23	American Hoechst Corporation	Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
AR241016A1 (es)	1983-03-08	1991-04-30	Bristol Myeres Squibb Company	"derivados de aminotiol cuaternario, procedimiento para prepararlos y procedimiento para preparar compuestos de carbapenem a partir de dichos derivados".
DE69008486T2 (de) *	1989-05-24	1994-09-15	Pharmacia Ab	Substituierte isoxazolidine und isoxazoline.
GB2264299B (en)	1992-02-19	1995-07-26	British Tech Group	Iso-oxazolidine derivatives
JP3118061B2 (ja) *	1992-03-12	2000-12-18	高砂香料工業株式会社	光学活性ヒドロキシルアミンの製造法
GB9226857D0 (en) *	1992-12-23	1993-02-17	Boyd Edward A	Pharmaceutical compositions
IL112099A (en)	1993-12-23	1999-07-14	Ortho Pharma Corp	N-oxides of 4-arylpiperazines and 4-arylpiperidines and pharmaceutical compositions containing them
DE69736390T2 (de) *	1996-10-07	2007-07-26	Merck Sharp & Dohme Ltd., Hoddesdon	Zns-penetrierende nk-1 rezeptorantagonisten als antidepressivum und / oder anxiolytikum
CA2291734A1 (en) *	1997-06-27	1999-01-07	Merck Sharp & Dohme Limited	Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents

2004
- 2004-06-01 AT AT04735609T patent/ATE348818T1/de active
- 2004-06-01 CA CA002526209A patent/CA2526209A1/en not_active Abandoned
- 2004-06-01 ES ES04735609T patent/ES2278321T3/es not_active Expired - Lifetime
- 2004-06-01 EP EP04735609A patent/EP1631557B1/de not_active Expired - Lifetime
- 2004-06-01 PT PT04735609T patent/PT1631557E/pt unknown
- 2004-06-01 NZ NZ544028A patent/NZ544028A/en not_active IP Right Cessation
- 2004-06-01 JP JP2006516370A patent/JP4648899B2/ja not_active Expired - Fee Related
- 2004-06-01 RU RU2006101055/04A patent/RU2006101055A/ru not_active Application Discontinuation
- 2004-06-01 KR KR1020057023634A patent/KR20060018253A/ko not_active Ceased
- 2004-06-01 PL PL04735609T patent/PL1631557T3/pl unknown
- 2004-06-01 DE DE602004003810T patent/DE602004003810T2/de not_active Expired - Lifetime
- 2004-06-01 SI SI200430202T patent/SI1631557T1/sl unknown
- 2004-06-01 US US10/559,180 patent/US7842689B2/en not_active Expired - Fee Related
- 2004-06-01 WO PCT/GB2004/002324 patent/WO2004111021A1/en not_active Ceased
- 2004-06-01 AU AU2004247462A patent/AU2004247462B2/en not_active Ceased
- 2004-06-01 BR BRPI0411124-9A patent/BRPI0411124A/pt not_active IP Right Cessation
- 2004-06-01 MX MXPA05013464A patent/MXPA05013464A/es active IP Right Grant
- 2004-06-01 DK DK04735609T patent/DK1631557T3/da active
2006
- 2006-01-11 NO NO20060178A patent/NO20060178L/no not_active Application Discontinuation
2009
- 2009-08-18 US US12/461,606 patent/US7842690B2/en not_active Expired - Fee Related
2010
- 2010-06-15 US US12/801,568 patent/US8053432B2/en not_active Expired - Fee Related
2011
- 2011-08-05 US US13/137,325 patent/US20120015947A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2278321T3 (es)	2007-08-01
DK1631557T3 (da)	2007-05-07
US7842689B2 (en)	2010-11-30
MXPA05013464A (es)	2006-03-17
JP4648899B2 (ja)	2011-03-09
EP1631557B1 (de)	2006-12-20
HK1087123A1 (en)	2006-10-06
RU2006101055A (ru)	2006-07-10
CA2526209A1 (en)	2004-12-23
DE602004003810T2 (de)	2007-10-11
NZ544028A (en)	2009-07-31
EP1631557A1 (de)	2006-03-08
WO2004111021A1 (en)	2004-12-23
NO20060178L (no)	2006-01-11
PL1631557T3 (pl)	2007-05-31
US20100256150A1 (en)	2010-10-07
AU2004247462B2 (en)	2010-09-02
JP2006527242A (ja)	2006-11-30
US20120015947A1 (en)	2012-01-19
PT1631557E (pt)	2007-03-30
DE602004003810D1 (de)	2007-02-01
KR20060018253A (ko)	2006-02-28
US8053432B2 (en)	2011-11-08
US20060142286A1 (en)	2006-06-29
US20090312329A1 (en)	2009-12-17
SI1631557T1 (sl)	2007-06-30
US7842690B2 (en)	2010-11-30
AU2004247462A1 (en)	2004-12-23
BRPI0411124A (pt)	2006-07-18

Legal Events

Date

Code

Title

Description

2007-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1631557

Country of ref document: EP

Publication	Publication Date	Title
EA200970493A1 (ru)	2009-10-30	Макроциклические ингибиторы вируса гепатита с
CY1110263T1 (el)	2015-01-14	Νεες ενωσεις ισοξαζολης και θειαζολης και η χρηση τους ως φαρμακα
DE60026318D1 (de)	2006-04-27	Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten
ATE293101T1 (de)	2005-04-15	Piperidine zur verwendung als orexin rezeptor antagonisten
JP2006521359A5 (de)	2010-08-19
DE69533727D1 (en)	2004-12-09	Anilin-derivate als stickstoffmonoxid synthase-inhibitoren
ATE348818T1 (de)	2007-01-15	Cyclische hydroxylamine als psychoactive verbindugen
BR0010324A (pt)	2002-01-08	Composto, composição farmacêutica, e, método de preparação de um composto
HUP0004477A2 (hu)	2001-02-28	Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk
ATE514730T1 (de)	2011-07-15	Polykarbonatharz und verfahren zu seiner herstellung
TW200637559A (en)	2006-11-01	3-propenylcefem derivative
DE60130766D1 (de)	2007-11-15	Serotoninwiederaufnahme-inhibitoren
ATE550332T1 (de)	2012-04-15	4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
TW200609220A (en)	2006-03-16	Tetrahydroisoquinolylsulphonamide derivatives, their preparation and their use in therapeutics
DE502007006121D1 (de)	2011-02-10	Elektrochemische herstellung sterisch gehinderter amine
DK1628968T3 (da)	2011-07-25	4-imidazolin-2-on-forbindelser
MX2022004265A (es)	2022-05-06	Compuesto de aldehido y metodo para producir el mismo y composicion de fragancia.
MXPA05009338A (es)	2005-11-04	7-alquenilamino-triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que los contienen.
ATE444323T1 (de)	2009-10-15	Neuartige epoxidverbindungen und verfahren zu ihrer herstellung
NO20023513L (no)	2002-08-26	Anvendelse av et ekstraheringsmiddel som et antiskummiddel ved fremstilling av vannfri maursyre
BRPI0518769A2 (pt)	2008-12-09	compostos
ATE383246T1 (de)	2008-01-15	Photosensible zusammensetzung und lithographischer druckplattenvorläufer, der diese zusammensetzung verwendet.
WO1999018085A3 (en)	1999-06-24	Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
NO20064299L (no)	2006-11-06	Indanolderivat
WO2005095405A3 (de)	2005-12-22	6-(2,6-dichlorphenyl)-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel